BAM Capital
Latest statistics and disclosures from BAM Capital's latest quarterly 13F-HR filing:
- Top 5 stock holdings are SPY, VRUS, IWM, BIIB, TRGT. These five stock positions account for 60.61% of BAM Capital's total stock portfolio.
- Added to shares of SPY (+$21.50M), VRUS (+$9.59M), IWM (+$8.99M), NFLX (+$5.66M), BIIB (+$5.56M), MDVN (+$5.31M), Barclays Bk Plc ipth s^p vix, TRGT, Research In Motion, Delcath Sys.
- Started new stock positions in INC Ventrus Biosciences, Delcath Sys, Barclays Bk Plc ipth s^p vix, ACAD, AFFY, Delcath Sys, IDCC, shares Agenus, INHX, NPSP, NFLX, BPAX, MDVN, IWM, Research In Motion.
- Reduced shares in these stocks: UTHR (-$24.51M), AMRN, GPRO, DCTH, ELN, VHC, VVUS, BBY, ARIA, AVEO.
- Sold out of its positions in AMRN, ARIA, AVEO, BBY, BMTI, FRX, GPRO, HGSI, ONXX, OREX, RPTP, VHC.
- As of Sept. 30, 2011, BAM Capital has $97.37M in assets under management (AUM). Assets under management dropped from a total value of $100.11M to $97.37M.
- Independent of market fluctuations, BAM Capital was a net buyer by $18.45M worth of stocks in the most recent quarter.
BAM Capital portfolio companies for quarter ending September 2011
| Ticker | Name | Portfolio Weight | Change | Share Count | Price | Last Trade |
|---|---|---|---|---|---|---|
| SPY | SPDR S&P; 500 ETF | 24.41 | +950.00% | 210000 | 113.17 | 165.02 |
| VRUS | Pharmasset | 11.71 | +528.00% | 138400 | 82.37 | 0.00 |
| IWM | iShares Russell 2000 Index | 9.24 | NEW | 140000 | 64.25 | 98.37 |
| BIIB | Biogen Idec | 8.90 | +179.00% | 93000 | 93.15 | 214.02 |
| TRGT | Targacept | 6.36 | +59.00% | 413094 | 15.00 | 4.86 |
| NFLX | Netflix | 5.82 | NEW | 50000 | 113.28 | 226.55 |
| MDVN | Medivation | 5.45 | NEW | 312813 | 16.97 | 46.06 |
| KERX | Keryx Biopharmaceuticals | 5.16 | +41.00% | 1675411 | 3.00 | 7.30 |
| VVUS | VIVUS | 4.49 | -40.00% | 541987 | 8.06 | 14.05 |
| Barclays Bk Plc ipth s^p vix | 4.40 | NEW | 80300 | 53.37 | 0.00 | |
| ELN | Elan Corporation | 2.49 | -58.00% | 230700 | 10.53 | 13.61 |
| Research In Motion | 2.12 | NEW | 101700 | 20.31 | 0.00 | |
| Delcath Sys | 1.89 | NEW | 550500 | 3.34 | 0.00 | |
| Delcath Sys | 1.76 | NEW | 511901 | 3.34 | 0.00 | |
| ACOR | Acorda Therapeutics | 1.22 | +79.00% | 59500 | 20.00 | 34.06 |
| XNPT | XenoPort | 0.97 | +2.00% | 160571 | 5.86 | 5.21 |
| UTHR | United Therapeutics Corporation | 0.80 | -96.00% | 20903 | 37.45 | 65.08 |
| IDCC | InterDigital | 0.54 | NEW | 11200 | 46.52 | 46.26 |
| DNDN | Dendreon Corporation | 0.40 | +83.00% | 42900 | 9.00 | 4.09 |
| LLY | Eli Lilly & Co. | 0.29 | 7700 | 37.01 | 52.97 | |
| AFFY | Affymax | 0.28 | NEW | 59857 | 4.48 | 1.05 |
| NPSP | NPS Pharmaceuticals | 0.24 | NEW | 36169 | 6.50 | 15.03 |
| INC Ventrus Biosciences | 0.24 | NEW | 26164 | 9.02 | 0.00 | |
| INHX | Inhibitex | 0.20 | NEW | 80329 | 2.46 | 0.00 |
| ACAD | ACADIA Pharmaceuticals | 0.17 | NEW | 152180 | 1.08 | 19.23 |
| shares Agenus | 0.13 | NEW | 273492 | 0.47 | 0.00 | |
| DCTH | Delcath Systems | 0.10 | -97.00% | 28900 | 3.36 | 0.59 |
| Genvec | 0.10 | -9.00% | 35000 | 2.86 | 0.00 | |
| BPAX | BioSante Pharmaceuticals | 0.07 | NEW | 30000 | 2.27 | 1.20 |
| GTXI | GTx | 0.05 | +24.00% | 15415 | 3.37 | 7.13 |
Past 13F-HR SEC Filings for BAM Capital
- BAM Capital 2011 Q2 - filed Aug. 15, 2011
- BAM Capital 2011 Q1 - filed May 16, 2011
- BAM Capital 2010 Q4 - filed Feb. 14, 2011